{"id":"W2048548454","doi":"10.1002/hep.23073","title":"A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naïve patients with chronic hepatitis C: ViSER1 results #","year":2009,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Valeant Pharmaceuticals International; FibroGen; Gilead Sciences; Biogen; GlaxoSmithKline; Pfizer; Bristol-Myers Squibb","keywords":"Ribavirin; Medicine; Chronic hepatitis; Internal medicine; Hepatitis C; Gastroenterology; Virology; Pharmacology; Virus","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001688929,0.0001968937,0.000720536,0.0001971557,0.00005367205,0.000003614301,0.0001292808,0.000105902,0.0000351393],"category_scores_gemma":[0.0002849559,0.0001277966,0.00005229097,0.0004739205,0.0002257505,0.0000513727,0.00006262168,0.0001989428,0.000003844402],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003179593,"about_ca_system_score_gemma":0.0002653594,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005132007,"about_ca_topic_score_gemma":0.01334777,"domain_scores_codex":[0.9980177,0.0002818154,0.0006351153,0.0003689284,0.000355293,0.0003411738],"domain_scores_gemma":[0.998711,0.000266711,0.0002029856,0.000578249,0.0001377812,0.0001032163],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03458967,0.008926625,0.8854197,0.00002616982,0.0001485294,0.00009931198,0.001249206,0.000005337731,0.0002474941,0.0000410774,0.0000342613,0.06921265],"study_design_scores_gemma":[0.1802116,0.04522451,0.7714795,0.00009468583,0.0001223143,0.000005577677,0.0000382085,0.0007629102,0.001153873,0.000003838446,0.0007933623,0.0001095761],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966716,0.0001356211,0.000002432071,0.0002894641,0.00005678114,0.001819947,0.00007517202,0.00001470428,0.000934258],"genre_scores_gemma":[0.9994214,0.0003588316,0.00002871966,0.00002750957,0.00001896062,0.0000230564,0.00004134023,0.00001561435,0.00006461101],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1456219,"threshold_uncertainty_score":0.7758094,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02752052217696191,"score_gpt":0.3417874933959204,"score_spread":0.3142669712189585,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}